We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Boosting Tumor Cell Drug Sensitivity

News   Oct 31, 2018 | Original story from the University of California San Diego

 
Boosting Tumor Cell Drug Sensitivity

Pancreatic cancer cells deficient in the expression of the human gene known as Schlafen 11 and resistant to chemotherapy (left panels) were re-sensitized to chemotherapeutic treatment (middle and right panels) by inhibiting the expression of the transfer RNA known as tRNA-Leu-TAA through specially designed antisense oligonucleotides. Credit: Manqing Li, Michael David Lab, UC San Diego

 
 
Advertisement
 

RELATED ARTICLES

Anti-malarial Drug Shows Promise in First Clinical Trial

News

A fast-acting anti-malarial compound was shown to be well tolerated and displayed promising anti-malarial effects in the first study in humans.

READ MORE

Protein Target for Future Antidepressants Identified

News

A recent study strongly suggests that the protein GPR56 is involved in the biology of depression, which could offer a novel target for new antidepressant drugs.

READ MORE

How Does SARS-CoV-2 Invade Our Bodies So Easily?

News

To understand how the novel coronavirus SARS-CoV-2 enters the body and does its damage, a team of researchers are adapting using tiny models of the nose, mouth, eyes and lungs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE